Mark Corbett, n/a

Senior Medical Affairs Director Lead Rhinology and Allergy
Senior Medical Affairs Director Lead Rhinology and Allergy

Poster(s):

• (409) Dupilumab effectiveness through 24 months in patients from the United States with CRSwNP enrolled in the global AROMA registry
  Wednesday, October 29, 2025